Next Article in Journal
Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
Next Article in Special Issue
Targeting Platelet Thrombin Receptor Signaling to Prevent Thrombosis
Previous Article in Journal
NMDA Receptor Antagonists for Treatment of Depression
Previous Article in Special Issue
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
Open AccessArticle

The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists

by Huayun Deng and Ye Fang *
Biochemical Technologies, Science and Technology Division, Corning Inc., Corning, NY 14831, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(4), 500-509; https://doi.org/10.3390/ph6040500
Received: 6 March 2013 / Revised: 20 March 2013 / Accepted: 1 April 2013 / Published: 8 April 2013
(This article belongs to the Special Issue GPCR Based Drug Discovery)
Nearly 1% of all clinically used drugs are catecholics, a family of catechol-containing compounds. Using label-free dynamic mass redistribution and Tango β-arrestin translocation assays, we show that several catecholics, including benserazide, catechol, 3-methoxycatechol, pyrogallol, (+)-taxifolin and fenoldopam, display agonistic activity against GPR35. View Full-Text
Keywords: GPR35; benserazide; catechol; pyrogallol GPR35; benserazide; catechol; pyrogallol
Show Figures

Figure 1

MDPI and ACS Style

Deng, H.; Fang, Y. The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists. Pharmaceuticals 2013, 6, 500-509.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop